Quince Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2019 | $8.9M | $124.4M | $51.2M |
| FY2020 | $17.2M | $189.5M | $66.8M |
| FY2021 | $14.6M | $133.2M | $69.7M |
| FY2022 | $3.3M | $103.9M | $44.6M |
| FY2023 | $82.8M | $167.9M | $20.8M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2019 | $8.9M | $124.4M | $51.2M |
| FY2020 | $17.2M | $189.5M | $66.8M |
| FY2021 | $14.6M | $133.2M | $69.7M |
| FY2022 | $3.3M | $103.9M | $44.6M |
| FY2023 | $82.8M | $167.9M | $20.8M |